{"nctId":"NCT01253577","briefTitle":"A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis","startDateStruct":{"date":"2009-12"},"conditions":["Chronic Sinusitis"],"count":105,"armGroups":[{"label":"Drug Coated","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Sinus Stent with drug coating"]},{"label":"Non coated","type":"PLACEBO_COMPARATOR","interventionNames":["Device: Non Coated Sinus Stent"]}],"interventions":[{"name":"Sinus Stent with drug coating","otherNames":[]},{"name":"Non Coated Sinus Stent","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has bilateral chronic sinusitis confirmed by CT scan and defined as inflammation of the mucosa of the nose and paranasal sinuses of at least 8 consecutive weeks' duration.\n* Patient is indicated for and has consented to FESS.\n* FESS successfully completed without significant complication that in the opinion of the physician would confound study results and the patient's anatomy remains amenable to Sinus Stent placement.\n\nCT Imaging Inclusion Criteria:\n\n* CS diagnosis confirmed and documented by CT Scan within 6 months of the procedure.\n* Patient has minimum total CT score (Lund-Mackay method) of 6. â€¢ Patient has bilateral ethmoid sinus disease confirmed by CT.\n\nExclusion Criteria:\n\n* insulin dependent diabetics\n* oral steroid dependent condition\n* glaucoma, ocular hypertension, posterior subcapsular cataracts\n* middle turbinate resection","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Sinuses Requiring Post-operative Intervention","description":"Post-operative interventions include either need for surgical adhesion lysis or the need for oral steroids prescription, as determined from video-endoscopies reviewed by a panel of independent blinded sinus surgeons.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3","spread":null},{"groupId":"OG001","value":"46.9","spread":null}]}]}]},{"type":"PRIMARY","title":"Percentage of Patients With Clinically Significant Increase in Intra-ocular Pressure","description":"clinically significant IOP elevation is a change from baseline of \\>10 mm Hg on sinus side with drug-coated implant but not on side with control implant","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Sinuses That Developed Frank Polyposis","description":"Frank polyposis means polyps grade 2 or 3, which was determined from video-endoscopies reviewed by a panel of independent blinded sinus surgeons.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.8","spread":null},{"groupId":"OG001","value":"34.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":105},"commonTop":["Sinusitis","Headache","Epistaxis","Bronchitis"]}}}